RPR/INGN-201 + radiotherapy provides supraadditive effects in prostate cancer xenograft models Nov. 17, 1999 No Comments
Lorus files IND seeking clearance for phase I/II clinical trials of GTI-2040 Nov. 17, 1999 No Comments
Kinase inhibitors developed at Boehringer Ingelheim as potential anticancer agents Nov. 17, 1999 No Comments
Preclinical data highlight Xcytrin's anticancer activity and novel mechanism of action Nov. 17, 1999 No Comments